Hôtel-Dieu de Québec
11 Côte du Palais
Québec, QC
Canada G1R 2J6
Dernières nouvelles
Information non disponible
- Aloui, MalekEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67530malek.aloui@crchudequebec.ulaval.ca
1401, 18e rue
G3.457
Québec, QC
Canada G1J 1Z4 - Anderson, AudreyEmployé+1 418-525-4444, poste 67513
- Becerra Perez, Maria MargaritaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67526Maria-Margarita.Becerra-Perez@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Bergeron, Karol-AnneEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67315
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Bordeleau, SophieEmployé
- Bouchard, AnnickEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67314annick.bouchard@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Boudreault, Marie-NicoleEmployéL'Hôtel-Dieu de Québecmarie-nicole.boudreault@crchudequebec.ulaval.ca
9 rue McMahon
Québec, QC
Canada G1R 3S3 - Bradley, MélanieEmployéHôpital Saint-Sacrement
1050, chemin Sainte-Foy
Québec, Québec
Canada G1S 4L8Hôpital de l'Enfant-Jésus+1 418-525-4444, poste 67525+1 418-691-5065melanie.bradley@chudequebec.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Brochu, Marie-PierreEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67512marie-pierre.brochu@chudequebec.camarie-pierre.brochu@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Cantin, WilliamEmployéHôpital de l'Enfant-Jésuswilliam.cantin@crchudequebec.ulaval.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Chabot, PatriciaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67310patricia.chabot@chudequebec.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Ezzine, HoudaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67542houda.ezzine@chudequebec.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Gingras, MaryseEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67322maryse.gingras@chudequebec.ca
1401, 18e rue
G2.468
Québec, QC
Canada G1J 1Z4 - Gyejacquot, SophieEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67540sophie.gyejacquot@chudequebec.casophie.gyejacquot@crchudequebec.ulaval.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Lavoie, SandyEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67309+1 418-691-5065sandy.lavoie.1@ulaval.caSandy.Lavoie@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Marcotte, CatherineEmployécatherine.marcotte@crchudequebec.ulaval.ca
- Métivier-Pinard, JulieEmployéHôpital de l'Enfant-Jésus+1 418-525-4444julie.metivier-pinard@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Nadeau, BiancaEmployé+1 418-525-4444bianca.nadeau@crchudequebec.ulaval.ca
- Ndayizigiye, AliceEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67308alice.ndayizigiye.1@ulaval.caAlice.Ndayizigiye@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - St-Pierre, DominiqueEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67524Dominique.St-Pierre@chudequebec.cadspierre@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Villemure, IsabelleEmployéHôpital de l'Enfant-Jésusisabelle.villemure@crchudequebec.ulaval.ca
1401, 18e rue
G2.456
Québec, QC
Canada G1J 1Z4
Stress-buffering effect of social support on immunity and infectious risk during chemotherapy for breast cancer
Article de revueBrain Behav Immun Health, 10 , 2021.
Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules
Article de revueClin Cancer Res, 27 (19), 2021.
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
Article de revueClin Transl Med, 11 (4), 2021.
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm
Article de revueCancers (Basel), 13 (7), 2021.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
Article de revueJAMA, 325 (13), 2021.
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial
Article de revueLancet Haematol, 7 (2), 2020.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study
Article de revueJAMA Oncol, 6 (6), 2020.
Insomnia, immunity, and infections in cancer patients: Results from a longitudinal study
Article de revueHealth Psychol, 39 (5), 2020.
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153
Article de revueJ Clin Oncol, 38 (33), 2020.
Management of complex renal cysts in Canada: results of a survey study
Article de revueBMC Urol, 20 (1), 2020.
Projets actifs
- Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, du 2019-10-01 au 2025-03-31